Market Snapshot
  • U.S.
  • Europe
  • Asia
Ticker Volume Price Price Delta
DJIA 16,408.54 -16.31 -0.10%
S&P 500 1,864.85 2.54 0.14%
NASDAQ 4,095.52 9.29 0.23%
Ticker Volume Price Price Delta
STOXX 50 3,155.81 16.55 0.53%
FTSE 100 6,625.25 41.08 0.62%
DAX 9,409.71 91.89 0.99%
Ticker Volume Price Price Delta
NIKKEI 14,611.38 95.11 0.66%
TOPIX 1,179.32 5.95 0.51%
HANG SENG 22,760.24 64.23 0.28%

CombiMatrix to Present at the Canaccord Genuity Medical Technology and Diagnostics Forum

CombiMatrix to Present at the Canaccord Genuity Medical Technology and
Diagnostics Forum

IRVINE, Calif., Nov. 28, 2012 (GLOBE NEWSWIRE) -- CombiMatrix Corporation
(Nasdaq:CBMX), a molecular diagnostics company performing DNA-based testing
services for cancer and developmental disorders, today announced that CEO Judd
Jessup is scheduled to present at the Canaccord Genuity Medical Technology and
Diagnostics Forum at 3:00 p.m. EST on Tuesday, December 4, 2012. The one-day
conference is being held at Le Parker Meridien in New York City.

To listen to the presentation via CombiMatrix's website, go to in the Investor/Events section
( A replay of the webcast will be
available for 90 days at the site after the presentation.

About CombiMatrix Corporation

CombiMatrix Corporation, through its wholly owned subsidiary, CombiMatrix
Molecular Diagnostics, Inc. (CMDX), is a molecular diagnostics laboratory
which offers DNA-based testing services to the prenatal, pediatric and
oncology markets. The Company performs genetic testing utilizing Microarray,
FISH, PCR and G-Band Chromosome Analysis. CMDX offers prenatal and pediatric
testing services for the detection of abnormalities of genes at the DNA level
beyond what can be identified through traditional technologies. CMDX was also
the first commercial clinical laboratory in the United States to make
comprehensive DNA-based genomic analysis of solid tumors, including breast,
colon, lung, prostate and brain tumors, available to oncology patients and
medical professionals. Additional information about CMDX is available at or by calling 1-800-710-0624.

CONTACT: Company Contact:
         R. Judd Jessup
         President & CEO, CombiMatrix Corporation
         Tel (949) 753-0624
         Investor Relations Contact:
         John Baldissera
         BPC Financial Marketing
         Tel (800) 368-1217
         Media Contact:
         Len Hall
         VP, Media Relations
         Allen & Caron
         Tel (949) 474-4300

CombiMatrix Corporation
Sponsored Links
Sponsored Links